United States · FDA National Drug Code directory
Ipratropium Bromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-7970_2c5fc3b9-e3f3-4120-947a-815d30502a3a
- Product NDC
- 0378-7970
- Form
- SOLUTION
- Composition / generic term
- Ipratropium Bromide
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101109
- Source listing expiry
- 20261231
Source-listed ingredients
- IPRATROPIUM BROMIDE — .5 mg/2.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 CARTON (0378-7970-52) / 25 AMPULE in 1 POUCH (0378-7970-62) / 2.5 mL in 1 AMPULE · 0378-7970-52
- 30 POUCH in 1 CARTON (0378-7970-55) / 1 AMPULE in 1 POUCH (0378-7970-31) / 2.5 mL in 1 AMPULE · 0378-7970-55
- 2 POUCH in 1 CARTON (0378-7970-91) / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE · 0378-7970-91
- 1 POUCH in 1 CARTON (0378-7970-93) / 30 AMPULE in 1 POUCH (0378-7970-64) / 2.5 mL in 1 AMPULE · 0378-7970-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →